|Time Commitment:||3 Hrs 15 min over 6 weeks|
|Target Professions:||DO, MD, MBBS, Nurse Practitioner, Nurse, Physician Assistant, Pharmacist|
|Target Specialties:||Neurology, Family Medicine, Internal Medicine, Pediatrics|
|Credits Available:||3.25 AMA PRA Category 1 Credit™|
As a result of the COVID-19 pandemic, we have learned valuable lessons pertinent to MS care. This includes knowledge about COVID-19 severity and infection risk (especially as it relates to DMT selection), a much greater understanding of how DMTs affect SARS-CoV-2 vaccine responses, ways to potentially optimize vaccine responses, and the role of telemedicine. This program covers some of these major lessons learned about MS care. The Gather-ed collaborative social learning platform establishes a network of providers who can support each other with the goal of learning and sharing best practices that will improve outcomes for patients with MS.
The following questions are intended to assess your knowledge and practice of key aspects in the management of patients with MS and COVID.
This module gives consideration to the risks of infection and infection severity in people with MS.
This module will discuss considerations for starting, continuing or switching DMTs during COVID-19.
The following questions are intended to assess your gained knowledge and practice of key aspects in the management of patients with MS and COVID.
Discuss the self-study modules, and the case studies, as a group.
Meet Mary, a 45-year-old female with secondary progressive multiple sclerosis.
Meet Bill, a 31-year-old patient diagnosed with relapsing-remitting multiple sclerosis.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the outcomes for your patients with MS.